Search Results

Your search for Ellin Berman, MD matches 2 pages

Showing 1 - 2

By The ASCO Post Staff / NCCN 2018 Annual Conference

Ellin Berman, MD, on CML: Disease Management During Pregnancy

Ellin Berman, MD, of Memorial Sloan Kettering Cancer Center, discusses the effects of TKI therapy on fetal development, its impact on pregnancy outcomes, and how to develop an effective treatment plan.

leukemia

By Ellin Berman, MD / December 25, 2017

Bosutinib for First-Line Use in Chronic Myeloid Leukemia: Is Three a Crowd?

BOSUTINIB ( BOSULIF) is the latest tyrosine kinase inhibitor that has shown a superior molecular response profile when compared with imatinib.1,2 An orally available dual SRC/ABL1 inhibitor, the drug was shown in preclinical studies to have a potent inhibitory activity against BCR-ABL1 and minimal ...

Nov

Today In Oncology

Search Results

Your search for Ellin Berman, MD matches 2 pages

Ellin Berman, MD, on CML: Disease Management During Pregnancy

Bosutinib for First-Line Use in Chronic Myeloid Leukemia: Is Three a Crowd?

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma